Guided Therapeutics (GTHP) Current Deferred Tax Assets (2012 - 2016)

Guided Therapeutics has disclosed Current Deferred Tax Assets across 5 years of filings, most recently posting $795000.0 for Q4 2016.

• Current Deferred Tax Assets for Q4 2016 came in at $795000.0, up 27.0% year-over-year; the trailing twelve-month figure through Dec 2016 was $795000.0 (up 27.0% YoY), and the FY2016 annual result was $795000.0, up 27.0% from the prior year.
• Current Deferred Tax Assets came in at $795000.0 for Q4 2016 at Guided Therapeutics, up from $626000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $795000.0 in Q4 2016 to a low of $277000.0 in Q4 2012.
• The 5-year median for Current Deferred Tax Assets is $466000.0 (2014), against an average of $490200.0.
• Across the five-year window, Current Deferred Tax Assets climbed 3.61% in 2013 and jumped 62.37% in 2014, its largest moves.
• Guided Therapeutics' Current Deferred Tax Assets stood at $277000.0 in 2012, then advanced by 3.61% to $287000.0 in 2013, then surged by 62.37% to $466000.0 in 2014, then soared by 34.33% to $626000.0 in 2015, then rose by 27.0% to $795000.0 in 2016.
• The last three Current Deferred Tax Assets figures came in at $795000.0 (Q4 2016), $626000.0 (Q4 2015), and $466000.0 (Q4 2014), per Business Quant data.